ARTL, NCM

Artelo Biosciences, Inc. (ARTL)

Price (as of October 25)

2.77USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

FNCH

Finch Therapeutics Group, Inc.

-0.12

ETTX

Entasis Therapeutics Holdings Inc.

-0.1

HOOK

HOOKIPA Pharma Inc.

-0.07

IBRX

ImmunityBio, Inc.

-0.07

HUMA

Humacyte, Inc.

-0.07

CING

Cingulate Inc.

-0.06

CVM

CEL-SCI Corporation

-0.06

AVRO

AVROBIO, Inc.

-0.06

HALO

Halozyme Therapeutics, Inc.

-0.06

FATE

Fate Therapeutics, Inc.

-0.06

Show more

Highest within Industry

Symbol Correlation

ATAI

Atai Life Sciences N.V.

0.32

ARQT

Arcutis Biotherapeutics, Inc.

0.25

ALVR

AlloVir, Inc.

0.24

AMTI

Applied Molecular Transport Inc.

0.24

ALXO

ALX Oncology Holdings Inc.

0.2

AMLX

Amylyx Pharmaceuticals, Inc.

0.2

ALZN

Alzamend Neuro, Inc.

0.18

AMAM

Ambrx Biopharma Inc.

0.17

APTX

Aptinyx Inc.

0.17

ARGX

argenx SE

0.16

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.